/**/ document.writeln("\n\n\n \n
\n \n \n \n \n \n \n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n\n \n \n\n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n\n\n\n\n\n\n\n \n\n \n \n\n\n\n
\n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n
Markets
Quote
Depth/LII
Charts
News
Historical
\n \n\n
\n \n
\n \n \n \n \n \n\n\n\n\n\n\n\n\n
\nSymbol: \n\n\n \nSymbol Lookup | Recent Quotes\n\n\n\n\n
\n\n\n
\n\n\n\n\n		powered by
  quotemedia.com
\n \n
\n \n \n\n
\n\n\n\n\n\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n \n\n \n \n \n\n \n\n
\n\n \n \n \n \n \n \n \n \n \n
Detailed Quote for Javelin Pharmaceuticals Inc (JAV) \n \n
\n\n\n\n
\n\n \n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n $ 1.17\n\n \n\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n \n\n  \n\n 0.02\n\n (+1.74%)\n\n \n\n \n\n \n\n \n\n Volume: 369.28 k\n\n \n\n \n\n\n\n 4:00 PM EST Feb 9, 2010\n\n\n\n \n\n
\n\n\n\n\n\n\n\n
\n\n
\n \n\n \n \n\n\n \n \n \n \n \n \n
\n \n \n \n \n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n \n \n \n \n \n \n\n
\n After Hours: \n $ 1.17 \n \n \n \n 0.00\n (0.00%)\n \n \n \n \n Volume: 1.76 k\n \n \n \n4:34 PM EST Feb 9, 2010\n\n \n
\n
\n \n \n \n \n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n 52 Week Information
\n
\n
52 Week High\n \"\"
\n \n
July 30,2009
\n \n
Close: \n 2.28\n
\n
\n
\n
52 Week Low\n \"\"
\n \n
May 14,2009
\n \n
Close: \n 1.01\n
\n
\n
\n
\n
\n
\n
\n \n \n
\n \n\n \n
\n \n \n\n\n \n \n
\n \n \n \n \n \n
\n \n \n\n\n \n \n \n \n \n \n \n \n\n\n\n \n
Today5d1m3m1ymore
\n\n 		\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n \n \n\n \n\n \n\n \n\n \n \n\n \n\n \n\n \n \n \n\n \n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n \n \n\n \n\n \n\n \n \n
\n \n \n \n
Last Price
1.17
\n 		\n\n \n \n \n
Change $
\n \n 0.02\n \n
\n 		\n \n\n \n \n
Change %
\n\n \n 1.74%\n \n
\n 		\n \n \n \n
Tick
\n \n   \n \n
\n
\n \n \n\n \n
Bid
1.10
\n 		\n \n \n \n\n
Bid Size
1500
\n 		\n \n \n \n
Ask
1.21
\n\n 		\n \n \n \n
Ask Size
100
\n
\n \n \n \n
Open
1.16
\n 		\n \n \n \n
High
1.21
\n 		\n\n \n \n \n
Low
1.16
\n 		\n \n\n \n \n
Prev Close
1.15
\n
\n \n\n \n \n
Last Trade
4:00
\n 		\n \n \n \n
Volume
369.28 k
\n 		\n \n \n \n
\n
52 Wk Hi
2.28
\n 		\n\n \n \n \n
52 Wk Low
1.01
\n
\n \n\n \n \n
Market Cap
74.72 m
\n 		\n \n \n \n
Ex-Div Date
N/A
\n 		\n \n \n \n \n \n\n
Div Rate
0.00
\n 		\n \n \n \n
Yield
0.00
\n\n
\n \n\n \n \n
Shares
63,861,716
\n 		\n \n \n \n
EPS (TTM)
-0.71
\n 		\n \n \n \n\n
PE Ratio
N/A
\n 		\n \n \n \n
\n\n
\n
\n
\n
\n
\n
\n close\n Exchange Information\n
\n
\n
Listed On
\n \n
American Stock Exchange (AMX)
\n
\n
\n
\n
\n
\n \n
Exchange
AMX
\n
\n \n
\n
\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n \n\n News and Media for Javelin Pharmaceuticals Inc\n\n \n\n  (JAV) \n\n \n\n \n\n\n
\n Sector News | Topic News\n
\n\n
\n
\n
Sector News
\n
Basic Materials
\n
  - Chemicals
\n
  - Energy
\n
  - Metals & Mining
\n
Conglomerates
\n
  - Conglomerates
\n
Consumer Goods
\n
  - Consumer Durables
\n
  - Consumer Non-Durables
\n
  - Automotive
\n
  - Food & Beverage
\n
  - Tobacco
\n
Financial
\n
  - Banking
\n
  - Financial Services
\n
  - Insurance
\n
  - Real Estate
\n
Healthcare
\n
  - Drugs
\n
  - Health Services
\n
Industrial Goods
\n
  - Aerospace/Defense
\n
  - Manufacturing
\n
  - Materials & Construction
\n
Services
\n
  - Leisure
\n
  - Media
\n
  - Retail
\n
  - Specialty Retail
\n
  - Wholesale
\n
  - Diversified Services
\n
  - Transportation
\n
Technology
\n
  - Computer Hardware
\n
  - Computer Software & Services
\n
  - Electronics
\n
  - Telecommunications
\n
  - Internet
\n
Utilities
\n
  - Utilities
\n\n
\n
Hide
\n
\n
\n
\n
Market News
\n\n
AMEX
\n
Nasdaq
\n
NYSE
\n
OTCBB
\n\n
Pink Sheets
\n
Mutual Funds
\n\n
Commodities
\n
TSX
\n\n
World Market News
\n
Asia Pacific
\n\n
Europe
\n
Corporate Actions
\n\n
Stock Buyback
\n
Dividends
\n
Earnings
\n
Stock Splits
\n\n
Insider Trading
\n
IPO's
\n\n
Business & Finance
\n\n
Antitrust
\n
Banking & Finance
\n\n
Capital Gains
\n
Mergers & Acquisitions
\n
Economy
\n\n
Consumer Price Index
\n
Bond/Stock Update
\n\n
Federal Reserve
\n
Foreign Exchange
\n
International Monetary Fund
\n
Interest Rates
\n\n
\n\n
Hide
\n
\n
\n
\n\n
\n\n\n\n \n\n \n\n
\n\n\n\n\n\n\n\n\n\n \n\n \n\n \n\n\n\n\n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n \n\n \n\n\n\n \n\n\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n\n\n \n\n
\n\n\n\n \n\n \n\n News for JAV\n\n \n\n \n\n \n\n \n\n \n\n \n\n
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Feb 03, 2010
\n\n \n\n\n\n
9:02 AM\n\n\n\n Myriad Pharmaceuticals to Present at BIO CEO & Investor Conference on February 8th - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Feb 02, 2010
\n\n \n\n\n\n
9:10 AM\n\n\n\n FDA Accepts Javelin Pharmaceuticals' Submission and Files New Drug Application for Dyloject(TM) - GlobeNewswire
8:55 AM\n\n\n\n FDA Accepts Javelin Pharmaceuticals' Dyloject(TM) New Drug Application for Formal Review - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Dec 22, 2009
\n\n \n\n\n\n
1:35 PM\n\n\n\n Finkelstein Thompson LLP Announces Investigation of Javelin Pharmaceuticals, Inc. - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Dec 21, 2009
\n\n \n\n\n\n
11:54 AM\n\n\n\n Levi & Korsinsky, LLP Investigates Possible Breach of Fiduciary Duty by the Board of Javelin Pharmaceuticals, Inc. - JAV - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Dec 18, 2009
\n\n \n\n\n\n
8:15 AM\n\n\n\n Myriad Pharmaceuticals to Acquire Javelin Pharmaceuticals - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Dec 02, 2009
\n\n \n\n\n\n
9:23 AM\n\n\n\n Javelin Pharmaceuticals Submits Dyloject(TM) New Drug Application to FDA for Management of Acute Moderate-to-Severe Pain in Adults - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Tue, Nov 10, 2009
\n\n \n\n\n\n
7:00 AM\n\n\n\n Javelin Pharmaceuticals, Inc. Reports Third Quarter 2009 Results - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Nov 04, 2009
\n\n \n\n\n\n
9:15 AM\n\n\n\n Javelin Pharmaceuticals to Announce Third Quarter 2009 Financial Results - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Oct 30, 2009
\n\n \n\n\n\n
9:25 AM\n\n\n\n Javelin Pharmaceuticals, Inc. Tops Up Balance Sheet Through Registered Direct Offering - Business Wire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Dec 04, 2008
\n\n \n\n\n\n
9:33 AM\n\n\n\n NASDAQ OMX and Leerink Swann to Co-Host HealthCare Industry Forum - GlobeNewswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Mon, Jan 22, 2007
\n\n \n\n\n\n
9:00 AM\n\n\n\n American Stock Exchange to Host First Annual Healthcare Conference in Boston on February 8, 2007 - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Oct 25, 2006
\n\n \n\n\n\n
7:45 AM\n\n\n\n Frost & Sullivan Names Javelin Pharmaceuticals Entrepreneurial Company of the Year for Intranasal Therapeutics - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jul 20, 2006
\n\n \n\n\n\n
9:57 AM\n\n\n\n American Stock Exchange Lists Common Stock of Javelin Pharmaceuticals, Inc. - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jul 13, 2006
\n\n \n\n\n\n
8:01 AM\n\n\n\n Javelin Pharmaceuticals, Inc. Receives Approval for Listing on the American Stock Exchange - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Fri, Jul 07, 2006
\n\n \n\n\n\n
8:05 AM\n\n\n\n Javelin Pharmaceuticals Wins Phase II SBIR Grant - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jul 06, 2006
\n\n \n\n\n\n
11:26 AM\n\n\n\n Javelin Pharmaceuticals CEO to Present at Leerink Swann's Emerging Technologies in Pain Medicine Roundtable and Conference - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, Jun 21, 2006
\n\n \n\n\n\n
8:05 AM\n\n\n\n Mark Matthews Joins Javelin Pharmaceuticals as VP of Commercial Affairs - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Thu, Jun 15, 2006
\n\n \n\n\n\n
8:30 AM\n\n\n\n Javelin Elects Martin Driscoll and Neil Flanzraich to Board - PR Newswire
\n\n\n\n \n\n \n\n \n\n \n\n \n\n
Wed, May 31, 2006
\n\n \n\n\n\n
11:42 AM\n\n\n\n Javelin Enrolls First Patient In Pivotal Phase III Postop Pain Study of Dyloject(TM) - PR Newswire
\n\n More News for JAV >>
\n\n
\n\n
\n\n\n \n \n \n\n \n \n \n \n
\n
\n \n \n\n
\n\n\n
Copyright © QuoteMedia.  \n\n\n Data delayed 15 minutes unless otherwise indicated (View delay times for all exchanges).  \n RT   Realtime, \n DL+   Realtime BATS,  \n EOD   End Of Day,  \n PD   Previous Day.  \n\n\n Market Data powered by QuoteMedia, fundamentals by Morningstar.  Terms of Use. 
\n
 
\n\n
\n \n
\n
\n");